Novartis
NVS
#62
Rank
$189.21 B
Marketcap
$92.57
Share price
-0.55%
Change (1 day)
-4.88%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Operating Margin for Novartis (NVS)

Operating Margin as of April 2024 (TTM): 17.27%

According to Novartis's latest financial reports and stock price the company's current Operating Margin is 17.27%. At the end of 2022 the company had an Operating Margin of 16.15%.

Operating Margin history for Novartis from 2001 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
202216.15%-67.32%
202149.43%149.69%
202019.80%7.79%
201918.37%-29.42%
201826.02%44.97%
201717.95%13.52%
201615.81%-2.05%
201516.14%-29.45%
201422.88%25.39%
201318.25%-6.58%
201219.53%7.65%
201118.14%-20.05%
201022.70%3.17%
200922.00%-1.38%
200822.31%16.04%
200719.22%-14.9%
200622.59%1.13%
200522.34%-8.67%
200424.46%0.21%
200324.40%-10.16%
200227.17%2.83%
200126.42%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
22.88% 32.48%๐Ÿ‡บ๐Ÿ‡ธ USA
34.61% 100.41%๐Ÿ‡บ๐Ÿ‡ธ USA
15.60%-9.67%๐Ÿ‡บ๐Ÿ‡ธ USA
18.21% 5.44%๐Ÿ‡ซ๐Ÿ‡ท France
27.73% 60.57%๐Ÿ‡บ๐Ÿ‡ธ USA
19.24% 11.41%๐Ÿ‡บ๐Ÿ‡ธ USA
5.63%-67.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
22.54% 30.52%๐Ÿ‡ฌ๐Ÿ‡ง UK
-20.53%-218.88%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.